Leflunomide for active rheumatoid arthritis

Lancet. 1999 May 29;353(9167):1883; author reply 1883-4. doi: 10.1016/S0140-6736(05)75088-1.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase III
  • Letter
  • Randomized Controlled Trial
  • Comment

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Arthritis, Rheumatoid / drug therapy*
  • Female
  • Humans
  • Isoxazoles / adverse effects*
  • Isoxazoles / therapeutic use
  • Leflunomide
  • Male
  • Middle Aged
  • Vasculitis, Leukocytoclastic, Cutaneous / chemically induced*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Isoxazoles
  • Leflunomide